"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up": Reply.
Larsen TL, Garresori H, Brekke J, Enden T, Frøen H, Jacobsen EM, Quist-Paulsen P, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA.
Larsen TL, et al. Among authors: garresori h.
J Thromb Haemost. 2022 Aug;20(8):1937-1939. doi: 10.1111/jth.15774.
J Thromb Haemost. 2022.
PMID: 35859282
Free article.
No abstract available.